
Company Number
06769895
Next Accounts
Sep 2025
Shareholders
timothy pearce
john martin
View AllGroup Structure
View All
Industry
Activities of head offices
Registered Address
unit 1 ravencroft court, buttington enterprise park butti, welshpool, powys, SY21 8SL
Website
http://chemostrat.comPomanda estimates the enterprise value of HAFREN SCIENTIFIC LTD at £2m based on a Turnover of £3.3m and 0.62x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of HAFREN SCIENTIFIC LTD at £0 based on an EBITDA of £-11k and a 4.74x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of HAFREN SCIENTIFIC LTD at £2.1m based on Net Assets of £1.1m and 1.99x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hafren Scientific Ltd is a live company located in welshpool, SY21 8SL with a Companies House number of 06769895. It operates in the activities of head offices sector, SIC Code 70100. Founded in December 2008, it's largest shareholder is timothy pearce with a 60% stake. Hafren Scientific Ltd is a established, small sized company, Pomanda has estimated its turnover at £3.3m with healthy growth in recent years.
Pomanda's financial health check has awarded Hafren Scientific Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
6 Weak
Size
annual sales of £3.3m, make it smaller than the average company (£20.2m)
£3.3m - Hafren Scientific Ltd
£20.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a slower rate (7.3%)
6% - Hafren Scientific Ltd
7.3% - Industry AVG
Production
with a gross margin of 46%, this company has a lower cost of product (33.7%)
46% - Hafren Scientific Ltd
33.7% - Industry AVG
Profitability
an operating margin of -7.7% make it less profitable than the average company (5.8%)
-7.7% - Hafren Scientific Ltd
5.8% - Industry AVG
Employees
with 55 employees, this is below the industry average (110)
55 - Hafren Scientific Ltd
110 - Industry AVG
Pay Structure
on an average salary of £36.3k, the company has a lower pay structure (£49.9k)
£36.3k - Hafren Scientific Ltd
£49.9k - Industry AVG
Efficiency
resulting in sales per employee of £60k, this is less efficient (£204.5k)
£60k - Hafren Scientific Ltd
£204.5k - Industry AVG
Debtor Days
it gets paid by customers after 57 days, this is later than average (45 days)
57 days - Hafren Scientific Ltd
45 days - Industry AVG
Creditor Days
its suppliers are paid after 38 days, this is close to average (42 days)
38 days - Hafren Scientific Ltd
42 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Hafren Scientific Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 23 weeks, this is more cash available to meet short term requirements (15 weeks)
23 weeks - Hafren Scientific Ltd
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 49.3%, this is a lower level of debt than the average (55.7%)
49.3% - Hafren Scientific Ltd
55.7% - Industry AVG
Hafren Scientific Ltd's latest turnover from December 2023 is £3.3 million and the company has net assets of £1.1 million. According to their latest financial statements, Hafren Scientific Ltd has 55 employees and maintains cash reserves of £307.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 3,300,890 | 3,848,628 | 2,731,839 | 2,806,622 | 6,237,228 | 4,652,429 | 4,261,616 | 4,250,648 | 5,657,758 | 6,202,249 | 5,420,708 | 4,475,465 | 3,692,919 | ||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 1,783,757 | 2,049,399 | 1,793,183 | 2,054,335 | 2,608,066 | 2,182,422 | 1,674,788 | 2,461,174 | 2,741,421 | 2,657,602 | 2,245,551 | 2,118,493 | 1,915,556 | ||
Gross Profit | 1,517,133 | 1,799,229 | 938,656 | 752,287 | 3,629,162 | 2,470,007 | 2,586,828 | 1,789,474 | 2,916,337 | 3,544,647 | 3,175,157 | 2,356,972 | 1,777,363 | ||
Admin Expenses | 1,771,965 | 2,024,602 | 1,711,308 | 1,603,627 | 2,943,765 | 2,365,706 | 2,403,179 | 3,068,726 | 3,155,487 | 3,012,954 | 2,392,047 | 1,684,168 | 1,039,660 | ||
Operating Profit | -254,832 | -225,373 | -772,652 | -851,340 | 685,397 | 104,301 | 183,649 | -1,279,252 | -239,150 | 531,693 | 783,110 | 672,804 | 737,703 | ||
Interest Payable | 51,020 | 48,550 | 22,971 | 49,137 | 41,656 | 38,313 | 43,904 | 45,277 | 29,280 | 518 | 37 | 2,234 | 1,341 | ||
Interest Receivable | 244 | 20,545 | 1,439 | 296 | 519 | 206 | 95 | 1,379 | 636 | 225 | 747 | 296 | 192 | ||
Pre-Tax Profit | -339,007 | -226,785 | -776,438 | -897,256 | 608,903 | 83,251 | 122,452 | -1,275,995 | -267,794 | 531,400 | 783,820 | 670,866 | 736,554 | ||
Tax | 104,272 | 88,455 | 219,895 | 98,980 | -20,360 | 219,321 | 25,801 | 194,177 | 317,017 | -148,175 | -172,068 | -264,248 | -242,615 | ||
Profit After Tax | -234,735 | -138,330 | -556,543 | -798,276 | 588,543 | 302,572 | 148,253 | -1,081,818 | 49,223 | 383,225 | 611,752 | 406,618 | 493,939 | ||
Dividends Paid | 20,000 | 20,000 | 22,100 | 66,300 | |||||||||||
Retained Profit | -234,735 | -138,330 | -556,543 | -798,276 | 588,543 | 302,572 | 148,253 | -1,081,818 | 49,223 | 363,225 | 591,752 | 384,518 | 427,639 | ||
Employee Costs | 1,993,996 | 2,206,220 | 2,028,052 | 2,446,048 | 2,696,518 | 2,349,581 | 1,958,147 | 2,868,762 | 3,137,077 | 2,611,658 | 2,042,443 | ||||
Number Of Employees | 55 | 58 | 58 | 69 | 67 | 58 | 48 | 55 | 85 | 72 | |||||
EBITDA* | -10,968 | 50,205 | -550,012 | -564,572 | 1,305,997 | 457,313 | 554,199 | -1,036,494 | 278,039 | 894,486 | 1,006,370 | 860,419 | 787,682 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 653,663 | 783,107 | 627,274 | 781,848 | 890,581 | 638,516 | 784,748 | 1,039,470 | 1,245,435 | 1,011,867 | 534,291 | 353,473 | 388,099 | 220,029 | 223,756 |
Intangible Assets | 89,549 | 124,089 | 158,629 | 231,814 | 280,391 | 221,963 | 216,046 | 219,021 | 306,623 | 317,680 | 235,560 | 234,353 | 128,823 | ||
Investments & Other | 16,908 | 5,001 | 5,001 | 710 | 100 | ||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 743,212 | 924,104 | 785,903 | 1,013,662 | 1,170,972 | 865,480 | 1,005,795 | 1,258,491 | 1,552,058 | 1,329,547 | 769,851 | 587,826 | 516,922 | 220,739 | 223,856 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 517,619 | 1,054,871 | 929,328 | 529,601 | 1,613,655 | 1,930,912 | 1,449,869 | 978,950 | 1,011,978 | 1,578,557 | 1,522,407 | 763,621 | 871,364 | 281,642 | 106,973 |
Group Debtors | 85,429 | 31,508 | 41,876 | 41,588 | 41,531 | 27,260 | |||||||||
Misc Debtors | 425,557 | 444,659 | 439,576 | 588,081 | 739,035 | 479,611 | 303,311 | 249,862 | 585,319 | 295,981 | 112,510 | 269,064 | 101,453 | ||
Cash | 307,899 | 329,715 | 665,491 | 1,342,031 | 1,395,834 | 583,367 | 413,945 | 400,410 | 824,065 | 379,970 | 968,927 | 1,227,482 | 913,145 | 21,205 | 38,436 |
misc current assets | |||||||||||||||
total current assets | 1,336,504 | 1,860,753 | 2,076,271 | 2,501,301 | 3,790,055 | 3,021,150 | 2,167,125 | 1,629,222 | 2,421,362 | 2,254,508 | 2,603,844 | 2,260,167 | 1,885,962 | 302,847 | 145,409 |
total assets | 2,079,716 | 2,784,857 | 2,862,174 | 3,514,963 | 4,961,027 | 3,886,630 | 3,172,920 | 2,887,713 | 3,973,420 | 3,584,055 | 3,373,695 | 2,847,993 | 2,402,884 | 523,586 | 369,265 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 187,269 | 249,424 | 159,465 | 177,811 | 177,878 | 286,190 | 238,448 | 190,075 | 127,585 | 364,841 | 263,538 | 247,709 | 475,329 | 436,107 | 292,346 |
Group/Directors Accounts | |||||||||||||||
other short term finances | 126,586 | 143,180 | 159,155 | 142,457 | 321,722 | 183,042 | 181,853 | 104,366 | 117,784 | 20,000 | |||||
hp & lease commitments | 70,461 | 74,109 | 19,094 | 27,054 | 25,152 | 57,414 | 91,304 | 56,578 | 18,133 | ||||||
other current liabilities | 286,951 | 456,537 | 522,790 | 646,842 | 1,016,018 | 854,924 | 297,372 | 293,171 | 252,595 | 312,367 | 806,246 | 918,003 | 642,205 | ||
total current liabilities | 671,267 | 923,250 | 860,504 | 994,164 | 1,540,770 | 1,324,156 | 775,087 | 678,916 | 554,542 | 715,341 | 1,069,784 | 1,165,712 | 1,117,534 | 436,107 | 292,346 |
loans | 186,313 | 312,899 | 456,078 | 394,307 | 407,033 | 237,109 | 420,543 | 335,707 | 431,974 | 78,333 | |||||
hp & lease commitments | 93,509 | 173,363 | 19,092 | 46,147 | 57,285 | 102,653 | 32,081 | ||||||||
Accruals and Deferred Income | 33,664 | 48,269 | 71,993 | 82,639 | 103,299 | 68,216 | 81,145 | 95,246 | 108,968 | 89,133 | 8,291 | ||||
other liabilities | 16,491 | 9,685 | 27,431 | 30,356 | |||||||||||
provisions | 24,926 | 24,926 | 24,926 | 24,926 | 29,639 | 18,922 | 22,018 | 31,862 | 60,643 | 52,982 | 40,628 | 43,016 | 28,013 | 21,004 | 22,998 |
total long term liabilities | 354,903 | 559,457 | 562,682 | 548,395 | 616,474 | 324,247 | 523,706 | 520,100 | 704,238 | 252,529 | 48,919 | 43,016 | 28,013 | 21,004 | 22,998 |
total liabilities | 1,026,170 | 1,482,707 | 1,423,186 | 1,542,559 | 2,157,244 | 1,648,403 | 1,298,793 | 1,199,016 | 1,258,780 | 967,870 | 1,118,703 | 1,208,728 | 1,145,547 | 457,111 | 315,344 |
net assets | 1,053,546 | 1,302,150 | 1,438,988 | 1,972,404 | 2,803,783 | 2,238,227 | 1,874,127 | 1,688,697 | 2,714,640 | 2,616,185 | 2,254,992 | 1,639,265 | 1,257,337 | 66,475 | 53,921 |
total shareholders funds | 1,053,546 | 1,302,150 | 1,438,988 | 1,972,404 | 2,803,783 | 2,238,227 | 1,874,127 | 1,688,697 | 2,714,640 | 2,616,185 | 2,254,992 | 1,639,265 | 1,257,337 | 66,475 | 53,921 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -254,832 | -225,373 | -772,652 | -851,340 | 685,397 | 104,301 | 183,649 | -1,279,252 | -239,150 | 531,693 | 783,110 | 672,804 | 737,703 | ||
Depreciation | 209,324 | 241,038 | 192,538 | 238,191 | 210,438 | 176,925 | 262,420 | 46,158 | 314,008 | 235,366 | 102,351 | 92,584 | 49,979 | 51,296 | 174,752 |
Amortisation | 34,540 | 34,540 | 30,102 | 48,577 | 410,162 | 176,087 | 108,130 | 196,600 | 203,181 | 127,427 | 120,909 | 95,031 | |||
Tax | 104,272 | 88,455 | 219,895 | 98,980 | -20,360 | 219,321 | 25,801 | 194,177 | 317,017 | -148,175 | -172,068 | -264,248 | -242,615 | ||
Stock | |||||||||||||||
Debtors | -502,433 | 120,258 | 251,510 | -1,234,951 | -43,562 | 684,603 | 524,368 | -368,485 | -277,241 | 239,621 | 602,232 | 59,868 | 691,175 | 174,669 | 106,973 |
Creditors | -62,155 | 89,959 | -18,346 | -67 | -108,312 | 47,742 | 48,373 | 62,490 | -237,256 | 101,303 | 15,829 | -227,620 | 39,222 | 143,761 | 292,346 |
Accruals and Deferred Income | -184,191 | -89,977 | -134,698 | -389,836 | 196,177 | 544,623 | -9,900 | 26,854 | -39,937 | -413,037 | -103,466 | 275,798 | 642,205 | ||
Deferred Taxes & Provisions | -4,713 | 10,717 | -3,096 | -9,844 | -28,781 | 7,661 | 12,354 | -2,388 | 15,003 | 7,009 | -1,994 | 22,998 | |||
Cash flow from operations | 349,391 | 18,384 | -734,671 | 374,743 | 1,427,781 | 581,300 | 84,261 | -413,269 | 602,765 | 207,310 | 142,045 | 599,484 | 542,328 | ||
Investing Activities | |||||||||||||||
capital expenditure | -242,873 | -159,566 | -159,617 | -538,021 | -775,988 | -405,203 | |||||||||
Change in Investments | -16,908 | 16,908 | -5,001 | 5,001 | -710 | 610 | 100 | ||||||||
cash flow from investments | 16,908 | -16,908 | 5,001 | -242,873 | -164,567 | -159,617 | -538,021 | -775,988 | -405,203 | ||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | -16,594 | -15,975 | 16,698 | -179,265 | 138,680 | 1,189 | 77,487 | -13,418 | 97,784 | 20,000 | |||||
Long term loans | -126,586 | -143,179 | 61,771 | -12,726 | 169,924 | -183,434 | 84,836 | -96,267 | 353,641 | 78,333 | |||||
Hire Purchase and Lease Commitments | -83,502 | 228,378 | -27,052 | -25,153 | 71,299 | -57,414 | -91,175 | -10,642 | 109,017 | 50,214 | |||||
other long term liabilities | 16,491 | -9,685 | -17,746 | -2,925 | 30,356 | ||||||||||
share issue | |||||||||||||||
interest | -50,776 | -28,005 | -21,532 | -48,841 | -41,137 | -38,107 | -43,809 | -43,898 | -28,644 | -293 | 710 | -1,938 | -1,149 | ||
cash flow from financing | -274,836 | 33,026 | 35,266 | -302,013 | 346,135 | -216,238 | 64,516 | -108,350 | 581,030 | 146,222 | 24,685 | -4,528 | 762,074 | ||
cash and cash equivalents | |||||||||||||||
cash | -21,816 | -335,776 | -676,540 | -53,803 | 812,467 | 169,422 | 13,535 | -423,655 | 444,095 | -588,957 | -258,555 | 314,337 | 891,940 | -17,231 | 38,436 |
overdraft | |||||||||||||||
change in cash | -21,816 | -335,776 | -676,540 | -53,803 | 812,467 | 169,422 | 13,535 | -423,655 | 444,095 | -588,957 | -258,555 | 314,337 | 891,940 | -17,231 | 38,436 |
Perform a competitor analysis for hafren scientific ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in SY21 area or any other competitors across 12 key performance metrics.
HAFREN SCIENTIFIC LTD group structure
Hafren Scientific Ltd has 5 subsidiary companies.
Ultimate parent company
HAFREN SCIENTIFIC LTD
06769895
5 subsidiaries
Hafren Scientific Ltd currently has 4 directors. The longest serving directors include Dr Carol Bell (Dec 2014) and Ms Victoria Ridge (Oct 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Carol Bell | United Kingdom | 66 years | Dec 2014 | - | Director |
Ms Victoria Ridge | United Kingdom | 49 years | Oct 2016 | - | Director |
Mr Manjit Jhooty | United Kingdom | 50 years | Dec 2016 | - | Director |
Dr Paul Carey | England | 58 years | Jan 2017 | - | Director |
P&L
December 2023turnover
3.3m
-14%
operating profit
-254.8k
+13%
gross margin
46%
-1.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.1m
-0.19%
total assets
2.1m
-0.25%
cash
307.9k
-0.07%
net assets
Total assets minus all liabilities
company number
06769895
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
December 2008
age
17
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
chemostrat international limited (September 2013)
accountant
-
auditor
PRITCHETT & CO BUSINESS ADVISERS LIMITED
address
unit 1 ravencroft court, buttington enterprise park butti, welshpool, powys, SY21 8SL
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to hafren scientific ltd. Currently there are 4 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HAFREN SCIENTIFIC LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|